Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Miljenko V. Pilepich"'
Autor:
Miljenko V. Pilepich, Kathryn Winter, Colleen A. Lawton, Robert E. Krisch, Harvey B. Wolkov, Benjamin Movsas, Eugen B. Hug, Sucha O. Asbell, David Grignon
Publikováno v:
Onkourologiâ, Vol 3, Iss 1, Pp 59-65 (2020)
The RTOG 85-31 study has indicated that adjuvant hormonotherapy is particularly effective in prostate cancer (PC) patients with a high Glisson score. Long-term adjuvant hormonotherapy is not warranted in patients with a total Glisson score of 2-6. Ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::faee9b657122ee73e694fa13da6d57da
https://oncourology.abvpress.ru/oncur/article/view/1089
https://oncourology.abvpress.ru/oncur/article/view/1089
Autor:
Jason A. Efstathiou, William U. Shipley, Matthew R. Smith, Gerald E. Hanks, Miljenko V. Pilepich, Kyounghwa Bae, Howard M. Sandler
Publikováno v:
European Urology. 54:816-824
Gonadotropin-releasing hormone agonists (GnRHa) are associated with greater risk of coronary heart disease and myocardial infarction in men with prostate cancer, but little is known about their potential effects on cardiovascular mortality. We assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d686c3a125af5a02fc6fd92fddc9dbf
https://doi.org/10.1016/j.eururo.2008.01.021
https://doi.org/10.1016/j.eururo.2008.01.021
Autor:
Colleen A. Lawton, Joycelyn L. Speight, P. Rubin, Kyounghwa Bae, Richard K. Valicenti, David J. Grignon, Mack Roach, R. Jeffrey Lee, Miljenko V. Pilepich, Harvey B. Wolkov
Publikováno v:
Journal of Clinical Oncology. 26:585-591
Purpose Radiation Therapy Oncology Group (RTOG) 8610 was the first phase III randomized trial to evaluate neoadjuvant androgen deprivation therapy (ADT) in combination with external-beam radiotherapy (EBRT) in men with locally advanced prostate cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8eb39ea638a40ca7a7edd9dc7906b5b
https://doi.org/10.1200/jco.2007.13.9881
https://doi.org/10.1200/jco.2007.13.9881
Autor:
Mary V. Graham, David W. Johnstone, James M Atkins, David S. Ettinger, Walter J. Curran, Miljenko V. Pilepich, Rebecca Paulus, Ritsuko Komaki, Jeffrey D. Bradley, Mitchell Machtay
Publikováno v:
Journal of Clinical Oncology. 23:3480-3487
Purpose To determine the overall survival, progression-free survival, and toxicity associated with concurrent paclitaxel/carboplatin and thoracic radiotherapy for completely resected patients with stage II and IIIA non–small-cell lung cancer (NSCLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66bf9dc7e7979470f550a396d7ca8300
https://doi.org/10.1200/jco.2005.12.120
https://doi.org/10.1200/jco.2005.12.120
Publikováno v:
Journal of Clinical Oncology. 23:800-807
Purpose To update the effect of immediate androgen suppression in conjunction with standard external-beam irradiation versus radiation alone on a group of histologically lymph node-positive patients with adenocarcinoma of the prostate. Materials and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bca1db67bec4929a5552f6a85bdcc930
https://doi.org/10.1200/jco.2005.08.141
https://doi.org/10.1200/jco.2005.08.141
Autor:
Miljenko V. Pilepich, Donald S. Kaufman, Howard M. Sandler, William U. Shipley, William J. Tester
Publikováno v:
Cancer. 97:2115-2119
In the United States, radical cystectomy is viewed as the gold standard and, with few exceptions, is the only treatment recommended for patients with invasive bladder cancer. In many areas of cancer treatment, however, the trend in the 1990s has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5b44971fe37aa8d60a961711e39fbb
https://doi.org/10.1002/cncr.11282
https://doi.org/10.1002/cncr.11282
Autor:
John B. Mesic, Colleen A. Lawton, William T. Sause, Kathryn Winter, Madhu John, David J. Grignon, Mitchell Machtay, P. Rubin, Miljenko V. Pilepich
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 50:1243-1252
Purpose: To test the hypothesis that androgen ablation before and during radiotherapy for locally advanced carcinoma of the prostate may, by reducing tumor bulk and enhancing tumor cell kill, improve locoregional control and ultimately survival. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72475f40f2377d759abab5bd7bfdcf8b
https://doi.org/10.1016/s0360-3016(01)01579-6
https://doi.org/10.1016/s0360-3016(01)01579-6
Publikováno v:
Urology. 54:495-502
Objectives. To evaluate the effect of immediate androgen suppression in conjunction with standard external beam irradiation (RT) versus RT alone on a group of men after prostatectomy who had indications for adjuvant treatment. Methods. A national pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f352b37bf3bfcc3886e675e35a7def0d
https://doi.org/10.1016/s0090-4295(99)00186-7
https://doi.org/10.1016/s0090-4295(99)00186-7
Autor:
John A Parsons, John D Earle, Roger W Byhardt, M.D. Gerald E. Hanks, Bahman Emami, Anthony H Russell, Philip Rubin, William Sause, Jan Buzydlowski, Miljenko V. Pilepich
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 40:765-768
Purpose: This study was conducted to see what fraction of prostate cancer patients with biopsy-proven nodes are free of cancer 10 years after radiation treatment. Methods and Materials: RTOG protocol #75-06 included 90 patients with biopsy-proven pel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24fa284bb3817693cdc32c19ad25e094
https://doi.org/10.1016/s0360-3016(97)00921-8
https://doi.org/10.1016/s0360-3016(97)00921-8
Autor:
Carlos A Perez, Karen L Martz, Kyu H Shin, William Sause, Sucha O Asbell, Miljenko V. Pilepich, R.L. Doggett
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 40:769-782
Purpose: To evaluate survival and time to metastatic disease in patients treated for localized prostatic carcinoma in a Phase III radiotherapy (RT) protocol, Radiation Therapy Oncology Group (RTOG) 77-06. Patients with T18N0M0 (A2) or T2N0M0 (B) dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a42cacf644ed7ca2100a972149ba2aa
https://doi.org/10.1016/s0360-3016(97)00926-7
https://doi.org/10.1016/s0360-3016(97)00926-7